Position in NAMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,886,331
-$906,837 QoQ
Shares Held
645,805
-9.3% QoQ
Ownership
0.540%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#34
of 198 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Derivatives in NAMS
reported options exposure · as of Jun 30, 2026CallValue
$1,301,376
CallShares
38,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. NAMS ranks #56 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in NAMS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,301,376 | 38,400 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $21,886,331 | 645,805 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $973,104 | 30,400 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $787,446 | 24,600 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $22,793,168 | 712,064 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,080,244 | 59,300 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $1,929,400 | 55,000 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $22,284,464 | 635,247 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,262,736 | 44,400 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $972,648 | 34,200 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $5,871,750 | 206,461 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $755,187 | 41,700 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $5,797,789 | 320,143 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $661,015 | 36,500 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $1,758,373 | 85,900 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $1,572,096 | 76,800 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $13,959,168 | 681,933 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $25,078,856 | 975,831 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $2,670,230 | 103,900 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $1,112,810 | 43,300 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $59,760 | 3,600 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $275,560 | 16,600 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $8,672,918 | 522,465 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $61,472 | 3,200 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $4,113,898 | 214,154 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $17,289 | 900 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $10,744,999 | 454,334 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $235,083 | 21,046 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $290,422 | 31,397 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||